Common questions about Foster (FAQ)
Q: Does Foster start working immediately, or does it take time to feel the effect?
The medicine Foster contains two components. The Formoterol component is a long-acting bronchodilator that begins to widen the airways quite rapidly. Official product information indicates that the rapid component typically begins to act quickly, within minutes of inhalation. The Beclometasone component provides anti-inflammatory control, which requires consistent daily use to achieve its full, long-term effect.
Q: What should I do if I accidentally miss a dose of Foster?
Regulatory guidance on missed doses generally states to take the forgotten dose as soon as you remember, unless it is almost time for your next scheduled dose. If the next dose is due soon, the missed dose should be skipped. Official guidance states that a double dose must not be taken to make up for a missed dose.
Q: Can Foster cause weight gain, or is that a common misunderstanding?
Official adverse reaction listings for this specific medicine do not frequently list weight gain as a common side effect. However, the corticosteroid component, Beclometasone, when used at high doses or over very long periods, has the potential to cause systemic effects that may rarely include weight changes.
Q: Are there any specific foods or drinks I should avoid while using Foster?
Regulatory documents generally do not list specific food or drink restrictions that must be avoided when using Foster. However, the medicine's formulation contains a small amount of ethanol (alcohol). Official information indicates that caution is advised for individuals with known alcohol sensitivity, as the Formoterol component's effects may be influenced.
Q: Is Foster approved for use in children under the age of 12?
Official regulatory approval for Foster is typically for adults and adolescents aged 12 years and older for the treatment of asthma. The safety and effectiveness of this specific combination product have not been established in children under 12 years of age, and its use in this younger population is generally not recommended by authorities.
Q: Will I have withdrawal symptoms if I stop using Foster suddenly?
Regulatory documentation advises that treatment with Foster should not be stopped abruptly. This caution is primarily due to the steroid component, which can affect the body's natural corticosteroid production. Stopping suddenly may lead to a loss of symptom control or rarely, symptoms of adrenal insufficiency. Any decision to change treatment must be made under medical supervision.
Q: Is there a maximum amount of Foster that I can safely use in one day?
Regulatory documentation establishes a maximum total daily dose for Foster, which must not be exceeded. The maximum limit is defined by the prescribed regimen, as published in the official prescribing information.
Q: Can I use Foster with a different type of inhaler at the same time?
Official safety information explicitly prohibits using Foster with other long-acting beta2-agonist (LABA) medicines due to the risk of additive cardiovascular exposure. For other types of inhalers, it is generally noted that the medicine may be used alongside a separate rapid-acting bronchodilator for rescue, but all co-administration should be reviewed by a prescribing professional.
Q: What is the connection between Foster and my adrenal glands?
The medicine is documented to have the potential to cause a systemic effect known as adrenal suppression. Adrenal suppression is a rare effect, particularly with long-term, high-dose use of inhaled corticosteroids, and it is officially noted as a potential risk.
Q: How long does one inhaler usually last for someone using it daily?
Foster inhalers are supplied with a defined number of doses, typically 120 doses per canister. For a standard regimen, the inhaler is designed to last for a set period. Official instructions advise the patient to discard the device when the dose counter reaches '0' to ensure accurate dosing.
Q: Is it normal to feel a shaky or nervous feeling after taking a dose?
Official adverse reaction listings include effects such as tremor (shaking) and nervousness. These physical feelings are generally classified as uncommon side effects and are related to the stimulating effect of the Formoterol component. Palpitations (a fast or pounding heartbeat) are also noted as a possible, uncommon reaction.
Q: Does using Foster affect my ability to drive or operate machinery?
Regulatory documentation usually states that Foster is not likely to have any effect on the ability to drive or use machinery. However, if a patient experiences side effects such as dizziness or tremor (shaking), it is officially advised that caution should be exercised.
Q: Can I drink alcohol while I am using Foster?
The medicine's effects on the cardiovascular system may be heightened by alcohol consumption, though alcohol is not strictly contraindicated. Official sources advise caution.
Q: What temperature should I keep my Foster inhaler at?
Official storage instructions state that Foster should be stored at a temperature not exceeding 25 C or 30 C depending on the region and specific formulation. It is officially advised to protect the inhaler from direct sunlight and extreme heat, as the canister is pressurized.
Q: Is there a chance of having an allergic reaction to Foster?
Yes, there is a chance of having an allergic reaction. Official regulatory documentation explicitly lists known hypersensitivity (a severe allergic reaction) to any component of Foster as an absolute reason not to use the drug.
Q: Is Foster effective for treating COPD or only asthma?
Official regulatory documents confirm that Foster is licensed for the regular maintenance treatment of asthma in adults and adolescents. It is also licensed for the symptomatic treatment of severe Chronic Obstructive Pulmonary Disease (COPD) in adult patients, where the use of a combination product is considered appropriate.
Q: Can using Foster make my bones weaker over time?
Long-term or high-dose use of inhaled corticosteroids, the drug class of the Beclometasone component, is associated with a potential risk of systemic effects, including reduced bone mineral density. Regulatory documents note that this may rarely be associated with osteoporosis (weakening of the bones), particularly for patients with existing risk factors.
Q: How does Foster relate to other combination inhalers that use similar ingredients?
Foster is classified as a fixed-dose combination (FDC) product. This means it combines two different types of medicine (an Inhaled Corticosteroid and a Long-Acting beta2-Agonist) into a single inhaler device. This ICS/LABA classification is a standard therapeutic approach used in the continuous management of chronic respiratory conditions.
Q: Are there specific instructions for cleaning and caring for the inhaler device?
Official instructions advise that the inhaler device may be cleaned with a dry cloth or tissue if needed. However, it is explicitly instructed not to clean the inhaler with water or other liquids, as it is essential to keep the device dry to ensure proper function and dosage delivery.
Q: Does using Foster make me more susceptible to infections?
For patients with Chronic Obstructive Pulmonary Disease (COPD), the corticosteroid component is associated with an increased incidence of pneumonia. Additionally, caution is generally advised for patients who have existing infections in the airways (such as fungal, viral, or tuberculosis), as steroids can potentially influence the body's immune response.
Q: What happens if I use the inhaler when it is almost empty?
Official device instructions advise the patient to discard the inhaler when the dose counter shows '0'. The purpose of this instruction is to ensure that the patient stops using the inhaler before the remaining doses may deliver an inaccurate or insufficient amount of the medicine.
Q: How do doctors monitor the effectiveness of Foster treatment?
Regulatory guidance states that the patient should be regularly reassessed by a doctor to ensure that the dosage remains appropriate. The effectiveness of the treatment is typically monitored through a clinical assessment of the patient’s symptoms and through professional measures of lung function.
Q: Does research indicate any differences in effectiveness based on age?
Official regulatory documents indicate that there is no need to adjust the dose specifically for elderly patients (typically those aged 65 and over). For adolescents (12-17 years), the same dosage as adults is generally used to manage asthma, indicating consistency in expected effectiveness across the approved adult and adolescent populations.
Q: Can using Foster affect my sleeping patterns?
Adverse reaction listings include effects such as restlessness and anxiety, which can potentially affect sleeping patterns. These are generally classified as uncommon side effects and are related to the Formoterol component, which has a stimulating effect.
Q: Does using Foster make me more likely to get thrush in my mouth?
Oral candidiasis (thrush in the mouth), which is caused by a fungus, is listed as a Common adverse reaction. This is related to the local effect of the Beclometasone (steroid) component. Official administration instructions advise rinsing the mouth with water and spitting it out after use to help reduce this risk.
Q: Can I use Foster when I am pregnant or breastfeeding?
Official documentation notes that Foster is not recommended for use during pregnancy or lactation unless the expected benefit to the patient is judged to outweigh any potential risk to the child. This is because there is limited or insufficient clinical data to definitively establish the medicine's safety in these specific populations.
Q: What if I travel to a high-altitude place; does that change how Foster works?
Published studies on pressurized metered-dose inhalers (pMDIs) generally indicate that the dose delivered by the device is not significantly affected by changes in altitude. The performance of the inhaler tends to remain consistent across different altitudes.
Q: What does the research say about stopping Foster and how to do it safely?
Regulatory documents state that treatment should not be stopped abruptly, and any decision to stop or change the dosage must be made under medical supervision. The safety caution is because sudden discontinuation may lead to a loss of control over the chronic condition, or rarely, symptoms related to adrenal insufficiency.
Q: Can Foster cause changes to my voice or throat irritation?
Yes. Adverse reaction listings classify dysphonia (a hoarse voice) and pharyngitis (sore throat or throat irritation) as Common side effects that have been reported with the use of the medicine.
